Concepedia

Publication | Open Access

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

236

Citations

21

References

2017

Year

Abstract

EudraCT number: 2013-004494-28; ClinicalTrials.gov identifier: NCT02065791.

References

YearCitations

Page 1